Back to top
more

iRadimed (IRMD)

(Delayed Data from NSDQ)

$69.57 USD

69.57
90,379

-1.12 (-1.58%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $69.50 -0.07 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

iRadimed (IRMD) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

iRadimed (IRMD) delivered earnings and revenue surprises of +8.89% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Integer (ITGR) Q2 Earnings Lag Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of -1.27% and +2.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Sell Stocks for June 12th

by Zacks Equity Research

LYB, IRMD and SONY have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2025.

Zacks Equity Research

IRadimed (IRMD) Lags Q1 Earnings Estimates

by Zacks Equity Research

iRadimed (IRMD) delivered earnings and revenue surprises of -2.33% and 0.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Integer (ITGR) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of 3.15% and 1.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

IRadimed (IRMD) Lags Q4 Earnings Estimates

by Zacks Equity Research

iRadimed (IRMD) delivered earnings and revenue surprises of -2.22% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Waters (WAT) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Waters (WAT) delivered earnings and revenue surprises of 1.99% and 1.82%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Here's Why Momentum in iRadimed (IRMD) Should Keep going

by Zacks Equity Research

iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

iRadimed (IRMD) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

IRadimed (IRMD) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

iRadimed (IRMD) delivered earnings and revenue surprises of 10.26% and 0.72%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

IRadimed (IRMD) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

iRadimed (IRMD) delivered earnings and revenue surprises of 16.67% and 1.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Acadia Healthcare (ACHC) Opens Facility to Serve California

by Zacks Equity Research

Acadia Healthcare (ACHC) conducts a ribbon-cutting ceremony for its Indio-based acute care facility, which aims to cater to the dire need for high-quality behavioral healthcare services in the region.

Zacks Equity Research

UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS

by Zacks Equity Research

UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.

Zacks Equity Research

Centene's (CNC) Ambetter Enhances Offerings With Broward Health

by Zacks Equity Research

Centene's (CNC) Health Insurance Marketplace brand Ambetter strengthens its provider network with Broward Health.

Zacks Equity Research

Centene (CNC) Wins Contract From Arizona's Medicaid Agency

by Zacks Equity Research

Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.

Nalak Das headshot

5 Small Hidden Gems for the Rest of 2023

by Nalak Das

We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX.

Zacks Equity Research

Humana's (HUM) 2024 MA Plans Promise a Wider Set of Benefits

by Zacks Equity Research

Humana (HUM) aims to expand the reach of its Medicare plans across newer U.S. counties in 2024 through integrating multiple lucrative benefits within them.

Zacks Equity Research

Zacks.com featured highlights include NVIDIA, iRadimed, Perdoceo Education and Axcelis Technologies

by Zacks Equity Research

NVIDIA, iRadimed, Perdoceo Education and Axcelis Technologies are part of the Zacks screen of the Week article.

Tirthankar Chakraborty headshot

4 Top Profitable Stocks to Invest in Using Net Income Ratio

by Tirthankar Chakraborty

NVIDIA (NVDA), iRadimed (IRMD), Perdoceo Education (PRDO) and Axcelis Technologies (ACLS) have been selected as the top picks with a high net income ratio.

Zacks Equity Research

Encompass Health (EHC) Up 41% in a Year: More Room for Growth?

by Zacks Equity Research

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.

Zacks Equity Research

Zacks.com featured highlights iRadimed, PulteGroup and NVIDIA

by Zacks Equity Research

iRadimed, PulteGroup and NVIDIA have been highlighted in this Screen of The Week article.

Zacks Equity Research

Community Health (CYH), Mindoula to Offer Mental Health Care

by Zacks Equity Research

Community Health (CYH) collaborates with Mindoula to enhance the availability of behavioral health resources to its affiliated provider network, who can now treat patients better.

Tirthankar Chakraborty headshot

Top 3 Profitable Stocks to Buy Now Using Net Income Ratio

by Tirthankar Chakraborty

iRadimed (IRMD), PulteGroup (PHM) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.

Zacks Equity Research

Select Medical (SEM) Up 18% Year to Date: More Room to Run?

by Zacks Equity Research

Select Medical (SEM) is well-poised for growth on the back of a credible healthcare facility portfolio built through buyouts and JVs coupled with strong cash-generating abilities.